12:00 AM
Nov 07, 2005
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Affectis Pharmaceuticals AG

Munich, Germany

Technology: Behavioral interference technology

Disease focus: Neurology

Clinical status: Preclinical

Founded: 2003 by Herbert Stadler,...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >